 Connection
Vera Fridman to Biomarkers
This is a "connection" page, showing publications Vera Fridman has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.625 |
|
|
|
-
McCray BA, Fridman V. Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth Disease. Neurology. 2024 Dec 24; 103(12):e210120.
Score: 0.384
-
Fridman V, Elafros M, Eid S, Reynolds EL, McCray B, Callaghan BC. Advances in the pathophysiology and treatment of diabetic peripheral neuropathy. BMJ. 2026 Mar 26; 392:e081217.
Score: 0.105
-
Fridman V, Sillau S, Ritchie A, Bockhorst J, Coughlan C, Araya P, Espinosa JM, Smith K, Lange EM, Lange LA, Ghormli LE, Drews KL, Zeitler P, Reusch JEB. Plasma neurofilament light chain concentrations are elevated in youth-onset type 2 diabetes and associated with neuropathy. J Peripher Nerv Syst. 2023 09; 28(3):460-470.
Score: 0.088
-
Fridman V, Oaklander AL, David WS, Johnson EA, Pan J, Novak P, Brown RH, Eichler FS. Natural history and biomarkers in hereditary sensory neuropathy type 1. Muscle Nerve. 2015 Apr; 51(4):489-95.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|